Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has gained attention for its potential to reduce smoking cravings alongside weight loss
By slowing digestion and altering gut motility, it creates the fullness and appetite control that make it effective, but those same mechanisms can also trigger nausea, bloating, or discomfort
The pill will be taken daily and the starting dose is 1.5mg, rising to 4mg, 9mg, and 25mg
Disrupted integrity of the fornix in first-episode schizophrenia
HSA and FSA accounts cover PlexusDx compounded semaglutide injections, making personalized timing guidance accessible without insurance
Schenk A, Ghallab A, Hofmann U et al (2017) Physiologically-based modelling in mice suggests an aggravated loss of clearance capacity after toxic liver damage